Apontis Pharma AG (XTER:APPH) Treasury Stock : €-0.17 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Apontis Pharma AG Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Apontis Pharma AG's treasury stock for the quarter that ended in Dec. 2024 was €-0.17 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Apontis Pharma AG Treasury Stock Historical Data

The historical data trend for Apontis Pharma AG's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apontis Pharma AG Treasury Stock Chart

Apontis Pharma AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Treasury Stock

Get a 7-Day Free Trial

-0.17

Apontis Pharma AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Treasury Stock	Get a 7-Day Free Trial							-0.17	-0.17	-0.17	-0.17	-0.17

Apontis Pharma AG Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Apontis Pharma AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apontis Pharma AG (XTER:APPH) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rolf-Schwarz-Schutte-Platz 1, Monheim, BY, DEU, 40789

Website

https://www.apontis-pharma.de

Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.

Executives

Bruno Wohlschlegel	Board of Directors
Thomas Milz	Board of Directors
Thomas Zimmermann	Chief Financial Officer
Karlheinz Gast	Board of Directors

Apontis Pharma AG Headlines

No Headlines